APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hospital Acquired Pneumonia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hospital Acquired Pneumonia Drugs Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchHospital Acquired Pneumonia Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Hospital Acquired Pneumonia Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Hospital Acquired Pneumonia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hospital Acquired Pneumonia Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Hospital Acquired Pneumonia Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Hospital Acquired Pneumonia Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hospital Acquired Pneumonia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hospital Acquired Pneumonia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hospital Acquired Pneumonia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hospital Acquired Pneumonia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hospital Acquired Pneumonia Drugs include Merck, GlaxoSmithKline, Bayer, AstraZeneca, Valneva, Meiji Holdings, Cubist Pharmaceutical, Basilea Pharmaceutica and Aridis Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hospital Acquired Pneumonia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hospital Acquired Pneumonia Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Hospital Acquired Pneumonia Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hospital Acquired Pneumonia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hospital Acquired Pneumonia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hospital Acquired Pneumonia Drugs sales, projected growth trends, production technology, application and end-user industry.

Hospital Acquired Pneumonia Drugs Segment by Company

Merck

GlaxoSmithKline

Bayer

AstraZeneca

Valneva

Meiji Holdings

Cubist Pharmaceutical

Basilea Pharmaceutica

Aridis Pharmaceutical

Achaogen

Hospital Acquired Pneumonia Drugs Segment by Type

Phase II

Early Phase (Phase I & II)

Hospital Acquired Pneumonia Drugs Segment by Application

Hospital Pharmacies

Drug Store

Retail Pharmacies

E-Commerce

Hospital Acquired Pneumonia Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Acquired Pneumonia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital Acquired Pneumonia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Acquired Pneumonia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hospital Acquired Pneumonia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hospital Acquired Pneumonia Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hospital Acquired Pneumonia Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Phase II Major Manufacturers Table 3. Early Phase (Phase I & II) Major Manufacturers Table 4. Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacies Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Retail Pharmacies Major Manufacturers Table 8. E-Commerce Major Manufacturers Table 9. Hospital Acquired Pneumonia Drugs Industry Trends Table 10. Hospital Acquired Pneumonia Drugs Industry Drivers Table 11. Hospital Acquired Pneumonia Drugs Industry Opportunities and Challenges Table 12. Hospital Acquired Pneumonia Drugs Industry Restraints Table 13. Global Hospital Acquired Pneumonia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Hospital Acquired Pneumonia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Hospital Acquired Pneumonia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Hospital Acquired Pneumonia Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 19. Global Hospital Acquired Pneumonia Drugs Sales by Region (2021-2026) & (Kg) Table 20. Global Hospital Acquired Pneumonia Drugs Sales by Region (2027-2032) & (Kg) Table 21. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Region (2021-2026) Table 22. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Region (2027-2032) Table 23. Global Hospital Acquired Pneumonia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Hospital Acquired Pneumonia Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Hospital Acquired Pneumonia Drugs Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 28. Global Hospital Acquired Pneumonia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Hospital Acquired Pneumonia Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Hospital Acquired Pneumonia Drugs Manufacturers, Product Type & Application Table 31. Global Hospital Acquired Pneumonia Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Hospital Acquired Pneumonia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Hospital Acquired Pneumonia Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Hospital Acquired Pneumonia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Hospital Acquired Pneumonia Drugs Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 40. Global Hospital Acquired Pneumonia Drugs Sales by Type (2021-2026) & (Kg) Table 41. Global Hospital Acquired Pneumonia Drugs Sales by Type (2027-2032) & (Kg) Table 42. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type (2021-2026) Table 43. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type (2027-2032) Table 44. Global Hospital Acquired Pneumonia Drugs Price by Type (2021-2026) & (US$/Kg) Table 45. Global Hospital Acquired Pneumonia Drugs Price by Type (2027-2032) & (US$/Kg) Table 46. Global Hospital Acquired Pneumonia Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Hospital Acquired Pneumonia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Hospital Acquired Pneumonia Drugs Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 52. Global Hospital Acquired Pneumonia Drugs Sales by Application (2021-2026) & (Kg) Table 53. Global Hospital Acquired Pneumonia Drugs Sales by Application (2027-2032) & (Kg) Table 54. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application (2021-2026) Table 55. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application (2027-2032) Table 56. Global Hospital Acquired Pneumonia Drugs Price by Application (2021-2026) & (US$/Kg) Table 57. Global Hospital Acquired Pneumonia Drugs Price by Application (2027-2032) & (US$/Kg) Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. Merck Hospital Acquired Pneumonia Drugs Product Portfolio Table 62. Merck Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Hospital Acquired Pneumonia Drugs Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Bayer Hospital Acquired Pneumonia Drugs Product Portfolio Table 72. Bayer Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. AstraZeneca Hospital Acquired Pneumonia Drugs Product Portfolio Table 77. AstraZeneca Recent Development Table 78. Valneva Company Information Table 79. Valneva Business Overview Table 80. Valneva Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Valneva Hospital Acquired Pneumonia Drugs Product Portfolio Table 82. Valneva Recent Development Table 83. Meiji Holdings Company Information Table 84. Meiji Holdings Business Overview Table 85. Meiji Holdings Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Meiji Holdings Hospital Acquired Pneumonia Drugs Product Portfolio Table 87. Meiji Holdings Recent Development Table 88. Cubist Pharmaceutical Company Information Table 89. Cubist Pharmaceutical Business Overview Table 90. Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Product Portfolio Table 92. Cubist Pharmaceutical Recent Development Table 93. Basilea Pharmaceutica Company Information Table 94. Basilea Pharmaceutica Business Overview Table 95. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Product Portfolio Table 97. Basilea Pharmaceutica Recent Development Table 98. Aridis Pharmaceutical Company Information Table 99. Aridis Pharmaceutical Business Overview Table 100. Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Product Portfolio Table 102. Aridis Pharmaceutical Recent Development Table 103. Achaogen Company Information Table 104. Achaogen Business Overview Table 105. Achaogen Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Achaogen Hospital Acquired Pneumonia Drugs Product Portfolio Table 107. Achaogen Recent Development Table 108. North America Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Hospital Acquired Pneumonia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Hospital Acquired Pneumonia Drugs Sales by Type (2021-2026) & (Kg) Table 111. North America Hospital Acquired Pneumonia Drugs Sales by Type (2027-2032) & (Kg) Table 112. North America Hospital Acquired Pneumonia Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 113. North America Hospital Acquired Pneumonia Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 114. North America Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Hospital Acquired Pneumonia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Hospital Acquired Pneumonia Drugs Sales by Application (2021-2026) & (Kg) Table 117. North America Hospital Acquired Pneumonia Drugs Sales by Application (2027-2032) & (Kg) Table 118. North America Hospital Acquired Pneumonia Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 119. North America Hospital Acquired Pneumonia Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 120. North America Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 124. North America Hospital Acquired Pneumonia Drugs Sales by Country (2021-2026) & (Kg) Table 125. North America Hospital Acquired Pneumonia Drugs Sales by Country (2027-2032) & (Kg) Table 126. North America Hospital Acquired Pneumonia Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 127. North America Hospital Acquired Pneumonia Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 128. United States Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 129. Canada Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 130. Europe Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Hospital Acquired Pneumonia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Hospital Acquired Pneumonia Drugs Sales by Type (2021-2026) & (Kg) Table 133. Europe Hospital Acquired Pneumonia Drugs Sales by Type (2027-2032) & (Kg) Table 134. Europe Hospital Acquired Pneumonia Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 135. Europe Hospital Acquired Pneumonia Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 136. Europe Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Hospital Acquired Pneumonia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Hospital Acquired Pneumonia Drugs Sales by Application (2021-2026) & (Kg) Table 139. Europe Hospital Acquired Pneumonia Drugs Sales by Application (2027-2032) & (Kg) Table 140. Europe Hospital Acquired Pneumonia Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 141. Europe Hospital Acquired Pneumonia Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 142. Europe Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 146. Europe Hospital Acquired Pneumonia Drugs Sales by Country (2021-2026) & (Kg) Table 147. Europe Hospital Acquired Pneumonia Drugs Sales by Country (2027-2032) & (Kg) Table 148. Europe Hospital Acquired Pneumonia Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 149. Europe Hospital Acquired Pneumonia Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 150. Germany Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 151. France Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 152. U.K. Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 153. Italy Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 155. Nordic Countries Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 156. China Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 157. China Hospital Acquired Pneumonia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 158. China Hospital Acquired Pneumonia Drugs Sales by Type (2021-2026) & (Kg) Table 159. China Hospital Acquired Pneumonia Drugs Sales by Type (2027-2032) & (Kg) Table 160. China Hospital Acquired Pneumonia Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 161. China Hospital Acquired Pneumonia Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 162. China Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 163. China Hospital Acquired Pneumonia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 164. China Hospital Acquired Pneumonia Drugs Sales by Application (2021-2026) & (Kg) Table 165. China Hospital Acquired Pneumonia Drugs Sales by Application (2027-2032) & (Kg) Table 166. China Hospital Acquired Pneumonia Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 167. China Hospital Acquired Pneumonia Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 168. Asia Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Hospital Acquired Pneumonia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Hospital Acquired Pneumonia Drugs Sales by Type (2021-2026) & (Kg) Table 171. Asia Hospital Acquired Pneumonia Drugs Sales by Type (2027-2032) & (Kg) Table 172. Asia Hospital Acquired Pneumonia Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 173. Asia Hospital Acquired Pneumonia Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 174. Asia Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Hospital Acquired Pneumonia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Hospital Acquired Pneumonia Drugs Sales by Application (2021-2026) & (Kg) Table 177. Asia Hospital Acquired Pneumonia Drugs Sales by Application (2027-2032) & (Kg) Table 178. Asia Hospital Acquired Pneumonia Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 179. Asia Hospital Acquired Pneumonia Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 180. Asia Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 184. Asia Hospital Acquired Pneumonia Drugs Sales by Country (2021-2026) & (Kg) Table 185. Asia Hospital Acquired Pneumonia Drugs Sales by Country (2027-2032) & (Kg) Table 186. Asia Hospital Acquired Pneumonia Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 187. Asia Hospital Acquired Pneumonia Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 188. Japan Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 189. South Korea Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 190. India Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 191. Australia Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 192. China Taiwan Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Hospital Acquired Pneumonia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Hospital Acquired Pneumonia Drugs Sales by Type (2021-2026) & (Kg) Table 197. SAMEA Hospital Acquired Pneumonia Drugs Sales by Type (2027-2032) & (Kg) Table 198. SAMEA Hospital Acquired Pneumonia Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 199. SAMEA Hospital Acquired Pneumonia Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 200. SAMEA Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Hospital Acquired Pneumonia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Hospital Acquired Pneumonia Drugs Sales by Application (2021-2026) & (Kg) Table 203. SAMEA Hospital Acquired Pneumonia Drugs Sales by Application (2027-2032) & (Kg) Table 204. SAMEA Hospital Acquired Pneumonia Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 205. SAMEA Hospital Acquired Pneumonia Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 206. SAMEA Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 210. SAMEA Hospital Acquired Pneumonia Drugs Sales by Country (2021-2026) & (Kg) Table 211. SAMEA Hospital Acquired Pneumonia Drugs Sales by Country (2027-2032) & (Kg) Table 212. SAMEA Hospital Acquired Pneumonia Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 213. SAMEA Hospital Acquired Pneumonia Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 214. Brazil Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 215. Argentina Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 216. Chile Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 217. Colombia Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 218. Peru Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 220. Israel Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 221. UAE Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 222. Turkey Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 223. Iran Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 224. Egypt Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Hospital Acquired Pneumonia Drugs Distributors List Table 228. Hospital Acquired Pneumonia Drugs Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Hospital Acquired Pneumonia Drugs Image Figure 2. Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hospital Acquired Pneumonia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Phase II Image Figure 5. Early Phase (Phase I & II) Image Figure 6. Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hospital Acquired Pneumonia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacies Image Figure 9. Drug Store Image Figure 10. Retail Pharmacies Image Figure 11. E-Commerce Image Figure 12. Global Hospital Acquired Pneumonia Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Hospital Acquired Pneumonia Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Hospital Acquired Pneumonia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Hospital Acquired Pneumonia Drugs Sales (2021-2032) & (Kg) Figure 18. Global Hospital Acquired Pneumonia Drugs Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 19. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Hospital Acquired Pneumonia Drugs Sales YoY (2021-2032) & (Kg) Figure 21. Europe Hospital Acquired Pneumonia Drugs Sales YoY (2021-2032) & (Kg) Figure 22. China Hospital Acquired Pneumonia Drugs Sales YoY (2021-2032) & (Kg) Figure 23. Asia (Excluding China) Hospital Acquired Pneumonia Drugs Sales YoY (2021-2032) & (Kg) Figure 24. South America, Middle East and Africa Hospital Acquired Pneumonia Drugs Sales YoY (2021-2032) & (Kg) Figure 25. Global Hospital Acquired Pneumonia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Hospital Acquired Pneumonia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Hospital Acquired Pneumonia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Hospital Acquired Pneumonia Drugs Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 32. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Hospital Acquired Pneumonia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Hospital Acquired Pneumonia Drugs Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 38. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Hospital Acquired Pneumonia Drugs Revenue Share by Type (2021-2032) Figure 41. North America Hospital Acquired Pneumonia Drugs Sales Share by Type (2021-2032) Figure 42. North America Hospital Acquired Pneumonia Drugs Revenue Share by Application (2021-2032) Figure 43. North America Hospital Acquired Pneumonia Drugs Sales Share by Application (2021-2032) Figure 44. North America Hospital Acquired Pneumonia Drugs Revenue Share by Country (2021-2032) Figure 45. North America Hospital Acquired Pneumonia Drugs Sales Share by Country (2021-2032) Figure 46. Europe Hospital Acquired Pneumonia Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Hospital Acquired Pneumonia Drugs Sales Share by Type (2021-2032) Figure 48. Europe Hospital Acquired Pneumonia Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Hospital Acquired Pneumonia Drugs Sales Share by Application (2021-2032) Figure 50. Europe Hospital Acquired Pneumonia Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Hospital Acquired Pneumonia Drugs Sales Share by Country (2021-2032) Figure 52. China Hospital Acquired Pneumonia Drugs Revenue Share by Type (2021-2032) Figure 53. China Hospital Acquired Pneumonia Drugs Sales Share by Type (2021-2032) Figure 54. China Hospital Acquired Pneumonia Drugs Revenue Share by Application (2021-2032) Figure 55. China Hospital Acquired Pneumonia Drugs Sales Share by Application (2021-2032) Figure 56. Asia Hospital Acquired Pneumonia Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Hospital Acquired Pneumonia Drugs Sales Share by Type (2021-2032) Figure 58. Asia Hospital Acquired Pneumonia Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Hospital Acquired Pneumonia Drugs Sales Share by Application (2021-2032) Figure 60. Asia Hospital Acquired Pneumonia Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Hospital Acquired Pneumonia Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Hospital Acquired Pneumonia Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Hospital Acquired Pneumonia Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Hospital Acquired Pneumonia Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Hospital Acquired Pneumonia Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Hospital Acquired Pneumonia Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Hospital Acquired Pneumonia Drugs Sales Share by Country (2021-2032) Figure 68. Hospital Acquired Pneumonia Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Hospital Acquired Pneumonia Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Phase II
  • Early Phase (Phase I & II)
Applications
  • Hospital Pharmacies
  • Drug Store
  • Retail Pharmacies
  • E-Commerce
Companies covered
  • Merck
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Valneva
  • Meiji Holdings
  • Cubist Pharmaceutical
  • Basilea Pharmaceutica
  • Aridis Pharmaceutical
  • Achaogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hospital Acquired Pneumonia Drugs Market by Type
  3. 1.2.1 Global Hospital Acquired Pneumonia Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Phase II
  5. 1.2.3 Early Phase (Phase I & II)
  6. 1.3 Hospital Acquired Pneumonia Drugs Market by Application
  7. 1.3.1 Global Hospital Acquired Pneumonia Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacies
  9. 1.3.3 Drug Store
  10. 1.3.4 Retail Pharmacies
  11. 1.3.5 E-Commerce
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Hospital Acquired Pneumonia Drugs Market Dynamics
  1. 2.1 Hospital Acquired Pneumonia Drugs Industry Trends
  2. 2.2 Hospital Acquired Pneumonia Drugs Industry Drivers
  3. 2.3 Hospital Acquired Pneumonia Drugs Industry Opportunities and Challenges
  4. 2.4 Hospital Acquired Pneumonia Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hospital Acquired Pneumonia Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hospital Acquired Pneumonia Drugs Revenue by Region
  3. 3.2.1 Global Hospital Acquired Pneumonia Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hospital Acquired Pneumonia Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Hospital Acquired Pneumonia Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hospital Acquired Pneumonia Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hospital Acquired Pneumonia Drugs Sales by Region
  9. 3.4.1 Global Hospital Acquired Pneumonia Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hospital Acquired Pneumonia Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Hospital Acquired Pneumonia Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Hospital Acquired Pneumonia Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hospital Acquired Pneumonia Drugs Revenue by Manufacturers
  2. 4.1.1 Global Hospital Acquired Pneumonia Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hospital Acquired Pneumonia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hospital Acquired Pneumonia Drugs Sales by Manufacturers
  6. 4.2.1 Global Hospital Acquired Pneumonia Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hospital Acquired Pneumonia Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hospital Acquired Pneumonia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hospital Acquired Pneumonia Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hospital Acquired Pneumonia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hospital Acquired Pneumonia Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hospital Acquired Pneumonia Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Hospital Acquired Pneumonia Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hospital Acquired Pneumonia Drugs Market CR5 and HHI
  16. 4.8.2 2025 Hospital Acquired Pneumonia Drugs Tier 1, Tier 2, and Tier 3
5 Hospital Acquired Pneumonia Drugs Market by Type
  1. 5.1 Global Hospital Acquired Pneumonia Drugs Revenue by Type
  2. 5.1.1 Global Hospital Acquired Pneumonia Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hospital Acquired Pneumonia Drugs Sales by Type
  6. 5.2.1 Global Hospital Acquired Pneumonia Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hospital Acquired Pneumonia Drugs Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hospital Acquired Pneumonia Drugs Price by Type
6 Hospital Acquired Pneumonia Drugs Market by Application
  1. 6.1 Global Hospital Acquired Pneumonia Drugs Revenue by Application
  2. 6.1.1 Global Hospital Acquired Pneumonia Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hospital Acquired Pneumonia Drugs Sales by Application
  6. 6.2.1 Global Hospital Acquired Pneumonia Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hospital Acquired Pneumonia Drugs Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hospital Acquired Pneumonia Drugs Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Hospital Acquired Pneumonia Drugs Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 GlaxoSmithKline
  8. 7.2.1 GlaxoSmithKline Company Information
  9. 7.2.2 GlaxoSmithKline Business Overview
  10. 7.2.3 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Product Portfolio
  12. 7.2.5 GlaxoSmithKline Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Hospital Acquired Pneumonia Drugs Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Hospital Acquired Pneumonia Drugs Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 Valneva
  26. 7.5.1 Valneva Company Information
  27. 7.5.2 Valneva Business Overview
  28. 7.5.3 Valneva Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Valneva Hospital Acquired Pneumonia Drugs Product Portfolio
  30. 7.5.5 Valneva Recent Developments
  31. 7.6 Meiji Holdings
  32. 7.6.1 Meiji Holdings Company Information
  33. 7.6.2 Meiji Holdings Business Overview
  34. 7.6.3 Meiji Holdings Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Meiji Holdings Hospital Acquired Pneumonia Drugs Product Portfolio
  36. 7.6.5 Meiji Holdings Recent Developments
  37. 7.7 Cubist Pharmaceutical
  38. 7.7.1 Cubist Pharmaceutical Company Information
  39. 7.7.2 Cubist Pharmaceutical Business Overview
  40. 7.7.3 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Product Portfolio
  42. 7.7.5 Cubist Pharmaceutical Recent Developments
  43. 7.8 Basilea Pharmaceutica
  44. 7.8.1 Basilea Pharmaceutica Company Information
  45. 7.8.2 Basilea Pharmaceutica Business Overview
  46. 7.8.3 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Product Portfolio
  48. 7.8.5 Basilea Pharmaceutica Recent Developments
  49. 7.9 Aridis Pharmaceutical
  50. 7.9.1 Aridis Pharmaceutical Company Information
  51. 7.9.2 Aridis Pharmaceutical Business Overview
  52. 7.9.3 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Product Portfolio
  54. 7.9.5 Aridis Pharmaceutical Recent Developments
  55. 7.10 Achaogen
  56. 7.10.1 Achaogen Company Information
  57. 7.10.2 Achaogen Business Overview
  58. 7.10.3 Achaogen Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Achaogen Hospital Acquired Pneumonia Drugs Product Portfolio
  60. 7.10.5 Achaogen Recent Developments
8 North America
  1. 8.1 North America Hospital Acquired Pneumonia Drugs Market Size by Type
  2. 8.1.1 North America Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Hospital Acquired Pneumonia Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Hospital Acquired Pneumonia Drugs Price by Type (2021-2032)
  5. 8.2 North America Hospital Acquired Pneumonia Drugs Market Size by Application
  6. 8.2.1 North America Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Hospital Acquired Pneumonia Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Hospital Acquired Pneumonia Drugs Price by Application (2021-2032)
  9. 8.3 North America Hospital Acquired Pneumonia Drugs Market Size by Country
  10. 8.3.1 North America Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hospital Acquired Pneumonia Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Hospital Acquired Pneumonia Drugs Market Size by Type
  2. 9.1.1 Europe Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hospital Acquired Pneumonia Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Hospital Acquired Pneumonia Drugs Price by Type (2021-2032)
  5. 9.2 Europe Hospital Acquired Pneumonia Drugs Market Size by Application
  6. 9.2.1 Europe Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hospital Acquired Pneumonia Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Hospital Acquired Pneumonia Drugs Price by Application (2021-2032)
  9. 9.3 Europe Hospital Acquired Pneumonia Drugs Market Size by Country
  10. 9.3.1 Europe Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hospital Acquired Pneumonia Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Hospital Acquired Pneumonia Drugs Market Size by Type
  2. 10.1.1 China Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Hospital Acquired Pneumonia Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Hospital Acquired Pneumonia Drugs Price by Type (2021-2032)
  5. 10.2 China Hospital Acquired Pneumonia Drugs Market Size by Application
  6. 10.2.1 China Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Hospital Acquired Pneumonia Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Hospital Acquired Pneumonia Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hospital Acquired Pneumonia Drugs Market Size by Type
  2. 11.1.1 Asia Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hospital Acquired Pneumonia Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Hospital Acquired Pneumonia Drugs Price by Type (2021-2032)
  5. 11.2 Asia Hospital Acquired Pneumonia Drugs Market Size by Application
  6. 11.2.1 Asia Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hospital Acquired Pneumonia Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Hospital Acquired Pneumonia Drugs Price by Application (2021-2032)
  9. 11.3 Asia Hospital Acquired Pneumonia Drugs Market Size by Country
  10. 11.3.1 Asia Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hospital Acquired Pneumonia Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hospital Acquired Pneumonia Drugs Market Size by Type
  2. 12.1.1 SAMEA Hospital Acquired Pneumonia Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hospital Acquired Pneumonia Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hospital Acquired Pneumonia Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Hospital Acquired Pneumonia Drugs Market Size by Application
  6. 12.2.1 SAMEA Hospital Acquired Pneumonia Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hospital Acquired Pneumonia Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hospital Acquired Pneumonia Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Hospital Acquired Pneumonia Drugs Market Size by Country
  10. 12.3.1 SAMEA Hospital Acquired Pneumonia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hospital Acquired Pneumonia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hospital Acquired Pneumonia Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hospital Acquired Pneumonia Drugs Value Chain Analysis
  2. 13.1.1 Hospital Acquired Pneumonia Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hospital Acquired Pneumonia Drugs Production Mode & Process
  6. 13.2 Hospital Acquired Pneumonia Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hospital Acquired Pneumonia Drugs Distributors
  9. 13.2.3 Hospital Acquired Pneumonia Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst